Evolution of the Average Target: Valneva SE

Evolution of the Target Price: Valneva SE

Changes in Analyst Recommendations: Valneva SE

29c.QmuBvKl-XRBUuo5ur7AwRhCMgMaG2_erhZA2uWGMhRs.BznRz-0kGGZgi-YA7MFGPyDD4a3koZPe8qcE1BXKvE8bKdPt0EptdgvY3w~6855b98e39d61cc1f1f8acf53a82d388
08-11 TD Cowen Initiates Valneva at Buy Rating, With $12 Price Target MT
05-13 French Analyst Ratings: Aramis and Valneva penalized following profit warnings Zonebourse
04-30 Schneider Electric, Capgemini, Societe Generale... stocks to watch today in Paris Zonebourse
04-22 Goldman Sachs Downgrades Valneva to Sell From Neutral, Adjusts Price Target to $4.90 From $7.50 MT
04-22 French Analyst Ratings: Thales, Vallourec and Valneva in the Spotlight Zonebourse
03-18 Valneva heads for fourth consecutive gain following annual results Zonebourse
01-20 Stifel Reiterates Buy Rating and Price Target on Valneva Zonebourse
01-06 Valneva, Biggest Gainer on SBF 120 and SRD at Close of Tuesday, January 6, 2026 Zonebourse
01-06 Valneva Surges on Positive Broker Comments Zonebourse
01-06 CAC 40 Lags Behind; Valneva in Demand Zonebourse
01-06 Valneva Posts Strongest Midday Gain on SBF 120, Tuesday, January 6, 2026 Zonebourse
01-06 Stock of the Day in Paris – Valneva Bolstered by Stifel Zonebourse
01-06 Stifel Raises Price Target for Valneva Zonebourse
01-06 Analysts' calls of the day: Bernstein favors Thales over BAE Systems and Dassault Aviation Zonebourse
11-20 Stifel Reiterates Buy Recommendation on Valneva Zonebourse
11-04 Valneva SE Announces Positive Results of Its Phase 1 Clinical Trial Investigating the Safety and Immunogenicity of VLA1601 CI
03/09/25 Valneva publishes positive data for its Lyme disease vaccine candidate, stock rises RE
26/08/25 Valneva: Stifel Adjusts Price Target Following FDA Suspension of Ixchiq License Zonebourse
26/08/25 Valneva: Stifel adjusts target price Zonebourse
12/08/25 Valneva: Oddo BHF confirms 'outperform' rating Zonebourse
14/07/25 Valneva Shares Surge After EMA Lifts Restriction on Chikungunya Vaccine RE
13/08/24 Valneva: Oddo BHF confirms its recommendation on the stock Zonebourse
24/06/24 Valneva rises after Canadian approval for its chikungunya vaccine RE
05/02/24 Valneva: Oddo BHF confirms its recommendation on the stock Zonebourse
02/01/24 Valneva: Oddo BHF remains positive Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+114.29%
+22.76%
+19.26%
+3.18%
+20.63%
+43.98%
+16.3%
-1.6%
+1.3%
-2.6%
Average +23.75%
Weighted average by Cap. +17.22%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.973EUR
Average target price
6.193EUR
Spread / Average Target
+108.30%
High Price Target
12.00EUR
Spread / Highest target
+303.63%
Low Price Target
2.150EUR
Spread / Lowest Target
-27.68%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. VLA Stock
  4. Consensus Valneva SE
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!